Expression of urocortin III/stresscopin in human heart and kidney.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JC.2003-031663PMID 15070962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993.

  2012cited by this paper
• Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

  2004cited by this paper
• Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females.

  2003cited by this paper
• Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion.

  2003cited by this paper
• Relaxation of rat arteries by urocortin: effects of gender and diabetes

  2003cited by this paper
• Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.

  2003cited by this paper
• Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression

  2002cited by this paper
• Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.

  2002cited by this paper
• Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway.

  2002cited by this paper
• KATP Channel Gene Expression Is Induced by Urocortin and Mediates Its Cardioprotective Effect

  2002cited by this paper
• Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.

  2002cited by this paper
• Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion.

  2002cited by this paper
• Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

  2001influential reference
• Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.

  2001cited by this paper
• Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century.

  2001cited by this paper
• Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

  2001cited by this paper
• Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response.

  2001cited by this paper
• Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

  2001influential reference
• Role of urotensin II in patients on dialysis.

  2001cited by this paper
• Cardiovascular actions of CRH and urocortin: an update.

  2001cited by this paper
• A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides.

  2001cited by this paper
• Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure.

  2000cited by this paper
• Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway*

  2000cited by this paper
• Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.

  2000cited by this paper
• Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy.

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• CRH-like peptides protect cardiac myocytes from lethal ischaemic injury.

  1999cited by this paper
• Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.

  1998cited by this paper
• Expression and protective effects of urocortin in cardiac myocytes.

  1998cited by this paper
• Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain.

  1998cited by this paper
• Cardiac inotropic actions of urocortin in conscious sheep.

  1997cited by this paper
• Urocortin expression in human pituitary gland and pituitary adenoma.

  1997cited by this paper
• Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.

  1996cited by this paper
• Urinary immunoreactive brain natriuretic peptide in patients with renal disease.

  1996cited by this paper
• Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland.

  1996cited by this paper
• Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.

  1993cited by this paper
• Human brain natriuretic peptide-like immunoreactivity in human brain.

  1992cited by this paper
• Immunoreactive endothelin in urine of patients with and without diabetes mellitus.

  1991cited by this paper

• The corticotropin‑releasing factor family in the urogenital system (Review).

  2025cites this paper
• The metabolic role of corticotropin-releasing hormone receptor 2 and its UCN peptides: emerging therapeutic potential

  2025cites this paper
• Corticotropin‐releasing hormone and obesity: From fetal life to adulthood

  2024cites this paper
• The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor

  2022cites this paper
• Expression patterns and evolution of urocortin and corticotropin‐releasing hormone genes in a cichlid fish

  2021cites this paper
• Urocortins as biomarkers in cardiovascular disease.

  2021cites this paper
• Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling

  2021cites this paper
• Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta‐analysis

  2021cites this paper
• Progress in understanding the roles of Urocortin3 (UCN3) in the control of appetite from studies using animal models.

  2019cites this paper
• Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Do urocortins have a role in treating cardiovascular disease?

  2019cites this paper
• CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms

  2019cites this paper
• Urocortins: Actions in health and heart failure.

  2017cites this paper
• Environmental Stressors and the Neuroendocrine Stress Response in Zebrafish: Consequences and Cytoprotective Mechanisms

  2017cites this paper
• The role of Fyn kinase in CRH regulation of energy homeostasis

  2017cites this paper
• Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure

  2016cites this paper
• Myocardial expression of Corticotropin-Releasing Factor Receptor 1 (CRFR1) is elevated in human heart failure and is modulated by genetic variation and a novel CRFR1 splice variant.

  2016cites this paper
• Cardiovascular effects of the sirtuin and urocortin systems in humans

  2016cites this paper
• Intraperitoneal injection urocortin-3 reduces the food intake of Siberian sturgeon (Acipenser baerii).

  2016cites this paper
• Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.

  2016cites this paper
• Characterization of urocortin as an anti-apoptotic protein in experimental ischemia-reperfusion model of the rat testis.

  2016cites this paper
• A functional (pro)renin receptor is expressed in human lymphocytes and monocytes.

  2015cites this paper
• Urocortin 2 in cardiovascular health and disease.

  2015cites this paper
• Secretion of urocortin I by human glioblastoma cell lines, possibly via the constitutive pathway.

  2015cites this paper
• The role of urocortin-2 in pulmonary arterial hypertension

  2014cites this paper
• Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.

  2014cites this paper
• The Corticotropin Releasing Factor System in the Kidney: Perspectives for Novel Therapeutic Intervention in Nephrology

  2013cites this paper
• Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction †

  2013cites this paper
• A New Potential Approach to Inotropic Therapy in the Treatment of Heart Failure: Urocortin

  2013cites this paper
• Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer

  2013cites this paper
• Increased expression of (pro)renin receptor in aldosterone-producing adenomas.

  2013cites this paper
• La digitación en la guitarra

  2013cites this paper
• Clinical Perspectives of Urocortin and Related Agents for the Treatment of Cardiovascular Disease

  2012cites this paper
• Regulation and Roles of Urocortins in the Vascular System

  2012cites this paper
• Distribution of Urocortins and Corticotropin-Releasing Factor Receptors in the Cardiovascular System

  2012influential citation
• Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland

  2012influential citation
• Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.

  2012cites this paper
• Hypertonicity induced modulation of gene transcription and translation of water regulatory molecules

  2011cites this paper
• ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.

  2011influential citation
• Urocortin 3 Inhibits Cardiac Sympathetic Nerve Activity in Conscious Sheep

  2011cites this paper
• Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland.

  2011cites this paper
• Relevance of urocortins to cardiovascular disease.

  2011cites this paper
• Placental urocortin-2 and -3: endocrine or paracrine functioning during healthy pregnancy?

  2010cites this paper
• Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats.

  2010cites this paper
• Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy.

  2010cites this paper
• Hypoxia and Preeclampsia: Increased Expression of Urocortin 2 and Urocortin 3

  2010cites this paper
• Presence of Kisspeptin-like Immunoreactivity in Human Adrenal Glands and Adrenal Tumors

  2010cites this paper
• Novel neurohormonal insights with therapeutic potential in chronic heart failure.

  2010cites this paper
• Expression of urocortins in canine myocardium and plasma levels in dogs with cardiac disease

  2010cites this paper
• Expression of (Pro)renin Receptor in the Human Brain and Pituitary, and Co‐localisation with Arginine Vasopressin and Oxytocin in the Hypothalamus

  2010cites this paper
• Urocortins in heart failure.

  2010cites this paper
• The corticotropin releasing factor system in cancer: expression and pathophysiological implications

  2010cites this paper
• Urinary proteins for the diagnosis of obstructive sleep apnea syndrome.

  2010cites this paper
• The Urinary Proteome

  2010cites this paper
• Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells.

  2009cites this paper
• The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.

  2009cites this paper
• Urocortin: a protective peptide that targets both the myocardium and vasculature

  2009influential citation
• Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.

  2009influential citation
• Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat.

  2009cites this paper
• The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.

  2009cites this paper
• Suppression of progesterone production by stresscopin/urocortin 3 in cultured human granulosa-lutein cells.

  2009influential citation
• Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes.

  2009cites this paper
• Placental urocortins and CRF in late gestation.

  2009cites this paper
• Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.

  2009cites this paper
• Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.

  2008cites this paper
• Phenylethanolamine N‐Methyltransferase Gene Expression in the Heart and Blood Pressure Response to Oxytocin Treatment in Rats Exposed to Voluntary Wheel Running

  2008cites this paper
• A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins.

  2008cites this paper
• CRF-2 Corticotropin-Releasing Factor Receptor

  2008cites this paper
• Urocortins in heart failure and ischemic heart disease.

  2008cites this paper
• Urocortina: biologia molecolare ed effetti sull'apparato cardiovascolare

  2007cites this paper
• Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

  2007cites this paper
• Expression of adrenomedullin2/intermedin in human brain, heart, and kidney.

  2007cites this paper
• Elevated Plasma Corticotrophin Release Factor Levels and In Utero Meconium Passage

  2007cites this paper
• Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists

  2007cites this paper
• The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.

  2006cites this paper
• Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine.

  2006cites this paper
• Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.

  2006cites this paper
• Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney.

  2006cites this paper
• Novel Markers of Hemodynamic Stress

  2006cites this paper
• Letter regarding article by Rademaker et al, "integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure".

  2006cites this paper
• Plasma urocortin 1 in sheep: regional sampling and effects of experimental heart failure.

  2006cites this paper
• CHAPTER 166 – Urotensin and Its Related Peptides

  2006cites this paper
• Human endometrium expresses urocortin II and III messenger RNA and peptides.

  2006cites this paper
• The roles of corticotropin-releasing factor-related peptides and their receptors in the cardiovascular system.

  2006cites this paper
• Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.

  2006cites this paper
• Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.

  2006influential citation
• Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions.

  2005cites this paper
• Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.

  2005cites this paper
• Integrated Hemodynamic, Hormonal, and Renal Actions of Urocortin 2 in Normal and Paced Sheep: Beneficial Effects in Heart Failure

  2005cites this paper
• Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.

  2005cites this paper
• Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.

  2004cites this paper
• Ancient evolution of stress-regulating peptides in vertebrates.

  2004cites this paper
• Urocortins as cardiovascular peptides.

  2004cites this paper
• Edinburgh Research Explorer Expression of urocortin peptides in canine myocardium and plasma

  year unknowncites this paper